(8′α,9′β-Dihydroxy)-3-farnesylindole

CAT:

804-HY-N10128-01

Size:

5 mg

Price:

Ask

For price, please contact [email protected]

UNSPSC Description: (8'α,9'β-Dihydroxy)-3-farnesylindole shows strong inhibitory activity (EC50 9.8 μM) against B. subtilis.
Target Antigen: Bacterial
Type: Natural Products
Related Pathways: Anti-infection
Applications: COVID-19-immunoregulation
Field of Research: Infection
Assay Protocol: https://www.medchemexpress.com/8-α-9-β-dihydroxy-3-farnesylindole.html
Solubility: 10 mM in DMSO
Smiles: C/C(C)=C\[C@@H]([C@@H](/C(C)=C/CC/C(C)=C/CC1=CNC2=CC=CC=C12)O)O
Molecular Weight: 353.50
References & Citations: [1]Maeda G, et al. Oxygenated Cyclohexene Derivatives from the Stem and Root Barks of Uvaria pandensis. J Nat Prod. 2021 Nov 21.
Shipping Conditions: Room temperature
Clinical Information: No Development Reported

Cat	Name
HY-N10128-03	(8′α,9′β-Dihydroxy)-3-farnesylindole
HY-N10128-02	(8′α,9′β-Dihydroxy)-3-farnesylindole
HY-N10128-01	(8′α,9′β-Dihydroxy)-3-farnesylindole
HY-N10885	α,β-Dihydro-4,6-dihydroxy-2-methoxy-3-methylchalcone
HY-B1204S-01	Histamine-α,α,β,β-d4 (dihydrochloride)
HY-B1204S-02	Histamine-α,α,β,β-d4 (dihydrochloride)
HY-W145656	α,β-Trehalose
HY-W751152-02	α,β-Thujone
HY-W751152-01	α,β-Thujone
HY-W751152-03	α,β-Thujone

Cat	Name
MBS5817360	(8'alpha,9'beta-Dihydroxy)-3-farnesylindole
sc-166174	α/β/γPAK ( (D-8)
sc-166174 PE	α/β/γPAK ( (D-8) PE
sc-166174 AC	α/β/γPAK ( (D-8) AC
sc-166174 HRP	α/β/γPAK ( (D-8) HRP
sc-166174 FITC	α/β/γPAK ( (D-8) FITC
sc-218580C	Histamine-α,α,β,β-d4 Dihydrochloride
sc-218580B	Histamine-α,α,β,β-d4 Dihydrochloride
B188892	Benzeneethan-α,α,β,β-d4-ol
sc-218580	Histamine-α,α,β,β-d4 Dihydrochloride